Scandion Oncology A/S: Cancellation of extraordinary general meeting
We hereby announce cancellation of the planned extraordinary general meeting of Scandion Oncology A/S (the “Company”) on Wednesday October 6, 2021.Following the notice on September 21, 2021 to convene for an extraordinary general meeting in the Company on October 6, 2021, shareholders representing more than 5% of the share capital have requested an additional extraordinary general meeting to be held in order to propose that the Board of Directors receive an authorization to establish a Share-Buyback program. The Board of Directors have not at present assessed whether it wants to make use